... Wace North America L.P. bought a new position in shares of CymaBay Therapeutics in the 2nd quarter worth $242,000. Ardsley Advisory Partners lifted its holdings in shares of CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners ...
http://ift.tt/2qvUtYs
No comments:
Post a Comment